Skip to main content
Skip to content
1 duplicate copy in the archive
Case File
d-18898House Oversight

New Leaf medical device fund outlines investment strategy and portfolio

Financial Record

The passage is a standard confidential fund overview describing investment focus, portfolio companies, and market conditions. It contains no allegations, financial flow details, or links to high‑profi New Leaf Fund (NLV‑III) targets later‑stage medical device companies with regulatory approval pathwa Emphasis on reduced competition and larger investment sizes due to fewer active VC firms. Portfoli

Date
November 11, 2025
Source
House Oversight
Reference
House Oversight #024052
Pages
1
Persons
1
Integrity
No Hash Available
Loading document viewer...

Ask AI About This Document

0Share
PostReddit
Review This Document

Forum Discussions

This document was digitized, indexed, and cross-referenced with 1,500+ persons in the Epstein files. 100% free, ad-free, and independent.

Support This ProjectSupported by 1,550+ people worldwide
Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.